Back to today’s briefing

Story perspectives

Vinay Prasad's FDA Exit Sparks Controversy in Biotech

8/2/2025

25 3

Center

Prasad's FDA Controversy

Vinay Prasad's removal from the FDA's biologics division has sparked a heated debate. His controversial stance on Sarepta's gene therapy and subsequent political fallout have left many divided. While some celebrate his exit as a win for biotech, others fear it could undermine the FDA's mission. Prasad's unwavering dedication to evidence-based medicine made him a polarizing figure in the field.

Right

Monarez Leads CDC

Dr. Susan Monarez has officially taken the helm as the CDC director, ready to champion the Make America Healthy Again initiative. Her appointment comes on the heels of Dr. Vinay Prasad's contentious exit from the FDA, where he faced backlash for challenging Trump's health policies. Monarez's background in public health and vaccine safety is already drawing mixed reactions.

1 of 2

Prasad's FDA Controversy

Vinay Prasad's removal from the FDA's biologics division has sparked a heated debate. His controversial stance on Sarepta's gene therapy and subsequent political fallout have left many divided. While some celebrate his exit as a win for biotech, others fear it could undermine the FDA's mission. Prasad's unwavering dedication to evidence-based medicine made him a polarizing figure in the field.

1 / 2